How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

CL

NASDAQ:CLSD
Get a brief AI stock analysisSaves ~ 15 minutes of your time

CL

Clearside Biomedical IncNASDAQ CLSD Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XNAS - Nasdaq

FAIR VALUE

Is CLSD undervalued compared to its fair value?

The fair value of CLSD stock is hidden USD. Relative to the market price of 1.17 USD Clearside Biomedical Inc is hidden.

Clearside Biomedical, Inc. is a biopharmaceutical company, which delivers therapies to the back of the eye through the suprachoroidal space. The company is headquartered in Alpharetta, Georgia and currently employs 36 fu...[More about valuation]

Clearside Biomedical Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0.086 $B

Price:

1.17 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.168

FINANCIALS

Clearside Biomedical financial for reporting period

Income Statement

0.0002 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0082 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.012 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

0.0002 B 100%
-0.0082 B -3569%
-0.012 B -5114%

Balance Sheet

0.04 B
-0.022 B

Financial Position Analysis

Assets

0.04 B
Current Assets
0.036 B
Total non-current assets
0.004 B

Total current liabilities
0.006 B
Total non-current liabilities
0.056 B

Cash Flow Statement

-0.0079 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0079 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Clearside Biomedical fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-95 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is CLSD attractive for investment based on fundamental analysis?

CLSD stock rating is hidden. Clearside Biomedical is a hidden by Eyestock methodology.

Get CLSD Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

-414

Gross Margin:

CFO / Debt ratio:

hidden

Current ratio:

5.579

Debt / Equity ratio:

ROE:

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

CLSD analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for CLSD to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Clearside Biomedical Inc competitors

LL

LLY

Eli Lilly and Co

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. The company is headquartered in Indianapolis, Indiana and currently employs ...

Discover

NO

NOVO B.CO

Novo Nordisk A/S

Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. The firm is also engaged i...

Discover

JN

JNJ

Johnson & Johnson

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. The company is headquartered in Ne...

Discover

Clearside Biomedical Inc dividends

CLSD dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About CLSD stock

About the company Clearside Biomedical Inc

Market cap $B

0.086

Dividend yield

Shares outstanding

61.3643 B

Clearside Biomedical, Inc. is a biopharmaceutical company, which delivers therapies to the back of the eye through the suprachoroidal space. The company is headquartered in Alpharetta, Georgia and currently employs 36 full-time employees. The company went IPO on 2016-06-02. The firm is focused on developing and delivering therapies to the back of the eye diseases through the suprachoroidal space (SCS). Its SCS injection platform utilizing its SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted delivery of a variety of therapies to the macula, retina or choroid to preserve and improve vision in patients with sight-threatening eye diseases. The company is focused on developing its own pipeline of small molecule product candidates for administration via its SCS Microinjector, and it also partners with companies developing other ophthalmic therapeutics to be administered using its SCS injection platform. Its lead product candidate, XIPERE, is a preservative-free suspension of the corticosteroid triamcinolone acetonide (TA), formulated for administration through suprachoroidal injection. Its pipeline includes CLS-AX, CLS-301 and Gene Therapy.

CLSD profile

  • Ticker

    CLSD

  • Country

    USA

  • Exchange

    XNAS - Nasdaq

  • Report currency

    USD - US dollar

  • IPO date

    02 June 2016

  • Sector

    Healthсare

  • Industry

    Pharmaceuticals

  • Employees

    36

  • City

    Alpharetta

  • Address

    900 North Point Parkway, Suite 200

  • Cusip

    185063104